Turnstone Biologics Corp. Reports Third Quarter 2024 Financial Results and Provides Recent Business Highlights
November 12, 2024 16:05 ET
|
Turnstone Biologics Corp.
Turnstone reports third quarter 2024 financial results and provides recent business highlights
Turnstone Biologics Presents Preclinical Data Highlighting Potential for Selected Tumor-Infiltrating Lymphocyte (TIL) Therapy in Solid Tumors at the 2024 Society for Immunotherapy of Cancer (SITC) Annual Meeting
November 05, 2024 09:01 ET
|
Turnstone Biologics Corp.
Turnstone Biologics presents preclinical data highlighting potential for Selected TIL therapy in solid tumors at SITC 2024
Turnstone Biologics Announces Strategic Restructuring to Prioritize Portfolio and Extend Financial Runway
October 11, 2024 06:00 ET
|
Turnstone Biologics Corp.
Turnstone Biologics announces strategic restructuring to prioritize portfolio and extend financial runway.
Turnstone Biologics to Present at the 2024 Bank of America Securities Health Care Conference
May 08, 2024 09:00 ET
|
Turnstone Biologics Corp.
Dr. Sammy Farah, Turnstone's President and CEO, to present at the 2024 Bank of America Securities Health Care Conference in Las Vegas, NV.
Turnstone Biologics Appoints William Waddill to its Board of Directors
April 16, 2024 09:00 ET
|
Turnstone Biologics Corp.
Turnstone Biologics appoints biotechnology industry veteran, William Waddill, to its Board of Directors.
Turnstone Biologics Corp. Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Recent Business Highlights
March 21, 2024 17:06 ET
|
Turnstone Biologics Corp.
Turnstone reports fourth quarter and full year 2023 financial results and provides recent business highlights.
Turnstone Biologics to Participate in the Piper Sandler 35th Annual Healthcare Conference
November 27, 2023 06:00 ET
|
Turnstone Biologics Corp.
Dr. Sammy Farah, President and CEO of Turnstone, will participate in a fireside chat at the Piper Sandler 35th Annual Healthcare Conference in New York.
Turnstone Biologics Expands Scientific Advisory Board with Appointment of Dr. Jeffrey S. Weber
October 30, 2023 06:00 ET
|
Turnstone Biologics Corp.
Internationally recognized cancer immunotherapy thought leader, Dr. Weber, will help guide Turnstone’s continued advancement of its Selected TIL therapies
Turnstone Biologics Corp. Announces Pricing of Upsized Initial Public Offering
July 21, 2023 02:15 ET
|
Turnstone Biologics Corp.
SAN DIEGO, July 20, 2023 (GLOBE NEWSWIRE) -- Turnstone Biologics Corp. (“Turnstone” or the “Company”) (Nasdaq: TSBX), a clinical-stage biotechnology company developing new medicines to treat and cure...